T

Tecon Biology Co Ltd
SZSE:002100

Watchlist Manager
Tecon Biology Co Ltd
SZSE:002100
Watchlist
Price: 6.99 CNY -2.51% Market Closed
Market Cap: ¥9.5B

Gross Margin

11%
Current
Improving
by 2.8%
vs 3-y average of 8.2%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
11%
=
Gross Profit
¥1.9B
/
Revenue
¥17.7B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
11%
=
Gross Profit
¥1.9B
/
Revenue
¥17.7B

Peer Comparison

Country Company Market Cap Gross
Margin
CN
Tecon Biology Co Ltd
SZSE:002100
9.5B CNY
Loading...
US
Archer-Daniels-Midland Co
XETRA:ADM
27.7B EUR
Loading...
US
Bunge Ltd
NYSE:BG
22.6B USD
Loading...
SG
Wilmar International Ltd
SGX:F34
21.8B SGD
Loading...
CN
Tongwei Co Ltd
SSE:600438
81.8B CNY
Loading...
MY
Sime Darby Plantation Bhd
KLSE:SIMEPLT
38.7B MYR
Loading...
US
Darling Ingredients Inc
NYSE:DAR
8.4B USD
Loading...
US
Ingredion Inc
NYSE:INGR
7.2B USD
Loading...
MY
IOI Corporation Bhd
KLSE:IOICORP
24.4B MYR
Loading...
CN
New Hope Liuhe Co Ltd
SZSE:000876
39.3B CNY
Loading...
MY
Kuala Lumpur Kepong Bhd
KLSE:KLK
20.8B MYR
Loading...

Market Distribution

Lower than 78% of companies in China
Percentile
22nd
Based on 8 314 companies
22nd percentile
11%
Low
-2 148% — 14.3%
Typical Range
14.3% — 34.6%
High
34.6% — 775.2%
Distribution Statistics
China
Min -2 148%
30th Percentile 14.3%
Median 23%
70th Percentile 34.6%
Max 775.2%

Tecon Biology Co Ltd
Glance View

Market Cap
9.5B CNY
Industry
Food Products

Tecon Biology Co Ltd has carved its niche in the rapidly evolving biotechnology sector, specializing in the development and production of bio-based products and solutions. At its core, the company leverages advanced biological science to create environmentally friendly products that satisfy a range of industrial needs. Operating at the intersection of science and sustainability, Tecon has focused its efforts on the use of microbial fermentation technology and genetic engineering to produce bio-products that support agricultural, pharmaceutical, and environmental applications. By advancing proprietary technological capabilities, the company has demonstrated a commitment to not only commercial success but also environmental stewardship, recognizing the increasing global emphasis on sustainable business practices. The company's financial model is centered around translating cutting-edge biological research into commercially viable products. Tecon Biology generates revenue by licensing its biotechnological innovations to major agricultural and pharmaceutical firms that seek sustainable and cost-effective alternatives to traditional chemical-based products. Additionally, Tecon manufactures and sells its own branded line of bio-products, such as bio-fertilizers and enzyme solutions, directly to end-users both domestically and internationally. This dual approach allows the company to capitalize on the growing demand for sustainable solutions while maintaining diverse revenue streams, thereby enhancing its resilience in the competitive biotech industry. Through strategic collaborations and continuous innovation, Tecon Biology has established itself as a formidable player in the global market, poised to address some of the biggest challenges facing the world today.

Intrinsic Value
11.46 CNY
Undervaluation 39%
Intrinsic Value
Price
T
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
11%
=
Gross Profit
¥1.9B
/
Revenue
¥17.7B
What is Tecon Biology Co Ltd's current Gross Margin?

The current Gross Margin for Tecon Biology Co Ltd is 11%, which is above its 3-year median of 8.2%.

How has Gross Margin changed over time?

Over the last 3 years, Tecon Biology Co Ltd’s Gross Margin has increased from 7.6% to 11%. During this period, it reached a low of 0.3% on Dec 31, 2023 and a high of 12.1% on Jun 30, 2025.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett